Brief: Biosergen Pauses Development Of Bsg005
04/04/2026 20:01
April 4 (Reuters) - Biosergen AB BIOSGN.ST: BIOSERGEN PAUSES DEVELOPMENT OF BSG005 BIOSERGEN AB - ESTIMATED CAPITAL INJECTION OF SEK 60 MILLION REQUIRED, NOT CONSIDERED FEASIBLE Source text: ID:nWkrb8kJ3Z Further company coverage: BIOSGN.ST ((Reuters.Briefs@thomsonreuters.com;))